- Home
- GNLX vs PFD Comparison
GNLX vs PFD Comparison
Compare GNLX & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- PFD
- Stock Information
- Founded
- GNLX 2001
- PFD 1990
- Country
- GNLX United States
- PFD United States
- Employees
- GNLX N/A
- PFD N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- PFD Investment Managers
- Sector
- GNLX Health Care
- PFD Finance
- Exchange
- GNLX Nasdaq
- PFD Nasdaq
- Market Cap
- GNLX 128.0M
- PFD 143.2M
- IPO Year
- GNLX 2023
- PFD N/A
- Fundamental
- Price
- GNLX $3.95
- PFD $11.78
- Analyst Decision
- GNLX Strong Buy
- PFD
- Analyst Count
- GNLX 4
- PFD 0
- Target Price
- GNLX $17.75
- PFD N/A
- AVG Volume (30 Days)
- GNLX 134.7K
- PFD 33.2K
- Earning Date
- GNLX 11-13-2025
- PFD 01-01-0001
- Dividend Yield
- GNLX N/A
- PFD 6.30%
- EPS Growth
- GNLX N/A
- PFD N/A
- EPS
- GNLX N/A
- PFD N/A
- Revenue
- GNLX N/A
- PFD N/A
- Revenue This Year
- GNLX N/A
- PFD N/A
- Revenue Next Year
- GNLX N/A
- PFD N/A
- P/E Ratio
- GNLX N/A
- PFD N/A
- Revenue Growth
- GNLX N/A
- PFD N/A
- 52 Week Low
- GNLX $1.95
- PFD $8.53
- 52 Week High
- GNLX $5.89
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- GNLX 63.93
- PFD 82.22
- Support Level
- GNLX $3.56
- PFD $11.70
- Resistance Level
- GNLX $3.61
- PFD $11.49
- Average True Range (ATR)
- GNLX 0.24
- PFD 0.06
- MACD
- GNLX 0.03
- PFD 0.03
- Stochastic Oscillator
- GNLX 84.42
- PFD 97.30
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.